Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2000, p. 682-687, Vol. 38, No. 2
Section of Infectious Diseases, Department of
Medical Sciences,1 and Section of
Pediatrics, Department of Women's and Children's
Health,2 Uppsala University Hospital, Uppsala,
Sweden
Received 19 July 1999/Returned for modification 25 August
1999/Accepted 3 November 1999
In a search for methods for subtyping of Bartonella
henselae in clinical samples, we amplified and sequenced a 701-bp
region in the 3' end of the ftsZ gene in 15 B. henselae isolates derived from cats and humans in the United
States and Europe. The ftsZ sequence variants that were
discovered were designated variants Bh ftsZ 1, 2, and 3 and
were compared with 16S rRNA genotypes I and II of the same isolates.
There was no ftsZ gene variation in the strains of 16S rRNA
type I, all of which were Bh ftsZ 1. The type II strains
constituted two groups, with nucleotide sequence variation in the
ftsZ gene resulting in amino acid substitutions at three
positions, one of which was shared by the two groups. One 16S rRNA type
II isolate had an ftsZ gene sequence identical to those of
the type I strains. Variants Bh ftsZ 1 and 2 were detected
in tissue specimens from seven Swedish patients with diagnoses such as
chronic multifocal osteomyelitis, cardiomyopathy, and lymphadenopathy.
Patients with similar clinical entities displayed either Bh
ftsZ variant. The etiological role of B. henselae in these patients was supported by positive
Bartonella antibody titers and/or amplification and
sequencing of a part of the B. henselae gltA gene. B. henselae ftsZ gene sequence variation may be useful in providing
knowledge about the epidemiology of various B. henselae strains in clinical samples, especially when isolation attempts have
failed. This report also describes manifestations of atypical Bartonella infections in Sweden.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Sequence Variation in the ftsZ Gene of
Bartonella henselae Isolates and Clinical Samples
*
Corresponding author. Mailing address: Section of
Infectious Diseases, Uppsala University Hospital, 751 85 Uppsala,
Sweden. Phone: 46-18-66 56 62. Fax: 46-18-665650. E-mail:
martin.holmberg{at}infektion.uu.se.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|